Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SOUTH SAN FRANCISCO, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI). The semi-annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Monday, May 20, 2013.
Help employers find you! Check out all the jobs and post your resume.
SOUTH SAN FRANCISCO, Calif., May 16, 2013 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index® (Nasdaq:^NBI). The semi-annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Monday, May 20, 2013.
Help employers find you! Check out all the jobs and post your resume.